The Relative Bioavailability of Temafloxacin Administered through a Nasogastric Tube With and Without Enterai Feeding
The relative bioavailability of a single oral dose of temafloxacin given with and without enterai feeding was determined in 18 healthy male volunteers in a randomised crossover study. Subjects were administered 600mg of temafloxacin orally as an intact tablet, or a crushed tablet suspended in water administered through a nasogastric tube with or without an enterai feeding solution [Osmolite® (Ross) 100 ml/h started 2h before administration of temafloxacin and continued for 4h postdose]. Plasma samples were analysed by a high performance liquid Chromatographic technique. Mean peak plasma concentrations (Cmax) for the oral tablet, crushed tablet, and crushed tablet with enterai feeding solution were 3.95 ± 1.02, 4.85 ± 0.69, and 4.69 ± 0.61 mg/L/70kg, respectively, and mean calculated area under the concentration-time curve from time 0 to 48h (AUC(0–48h)) values were 48.1 ± 11.0,54.5 ± 6.52, and 49.7 ± 5.89 mg/L · h/70kg, respectively. In terms of AUC(0–48h) and Cmax, the relative bioavailability of temafloxacin after nasogastric delivery of crushed temafloxacin given with and without an enterai feeding solution was equivalent to the reference oral regimen.
KeywordsEnteral Feeding Pefloxacin Enoxacin Relative Bioavailability Fleroxacin
Unable to display preview. Download preview PDF.
- Gibaldi M, Perrier D. Absorption kinetics and bioavailability. In Pharmacokinetics, 2nd ed., revised and expanded, p. 145, Marcel Dekker Inc., New York, 1982Google Scholar
- Granneman RG, Varga LA. High performance liquid chromatography for the detection of temafloxacin in biological matrices. Journal of Chromatography, in press, 1991Google Scholar
- Höffken G, Lode H, Wiley R, Glatzel TD, Sievers D, et al. Pharmacokinetics and bioavailability of ciprofloxacin and ofloxacin: effect of food and antacid intake. Reviews of Infectious Diseases 10 (Suppl 1): 138–139, 1988Google Scholar
- Lode H, Hampel B, Wachter T, Borner K, Koeppe P. Single dose pharmacokinetics of fleroxacin in volunteers, fasting, after standard breakfast and antacids. Abstract. Workshop on Fleroxacin (Ro 23-6240): a new oral once-a-day quinolone. 15th International Congress of Chemotherapy, 19–24 July, 1987Google Scholar
- Nix DE, Wilton JH, Schentag JJ, Parpia SH, Norman A, et al. Inhibition of norfloxacin absorption by antacids and sucralfate. Abstract. 2nd International Symposium on New Quinolones, Geneva, 25–27 Aug, 1988Google Scholar
- Seelmann R, Mahr G, Sorgel F, Gottschalk B, Granneman R, et al. The effect of antacids and cimetidine on the pharmacokinetics of temafloxacin. Program Abstracts, 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, Texas, 1989Google Scholar